Choose your Region

Are you sure you want to proceed?

You will be leaving the Cook Medical website that you were viewing and going to a Cook Medical website for another region or country. Not all products are approved in all regulatory jurisdictions. The product information on these websites is intended only for licensed physicians and healthcare professionals.

Search Cook Medical

Newsroom
March 21st, 2011

Cook Pharmica Announces Promotion of Steve Perry to Vice President of Drug Substance Operations


Bloomington, Ind. – Steve Perry has been promoted to vice president of drug substance operations, Cook Pharmica announced recently. Perry will continue to lead the drug substance business unit and will assume responsibility for the engineering function in his new role.

Perry joined Cook in 2010 with more than 20 years of experience in biopharmaceutical manufacturing operations. He has held numerous management roles and has extensive experience in large-scale therapeutic monoclonal antibody production, contract manufacturing and bioprocess engineering. Perry most recently served as director of drug substance operations at Cook Pharmica.

“We are proud to add Steve Perry to our executive team and look forward to his continued contribution to our drug substance operations in his expanded role,” said Tedd Green, president of Cook Pharmica. “His experiences in running large-scale commercial manufacturing operations, coupled with his previous contract manufacturing experience, have proven invaluable.”

Originally from West Lafayette, Ind., Steve earned his bachelor’s and master’s degrees in chemical engineering from Purdue University and the Massachusetts Institute of Technology, respectively. He also earned a master’s in business administration from Northwestern University.

“I am grateful for the recognition and for the confidence the company has placed in me,” Perry said. “I consider myself fortunate to work for Cook Pharmica, and I am looking forward to contributing further to the company’s success in my new position.”

About Cook Pharmica
Cook Pharmica is a biopharmaceutical contract development and manufacturing organization (CDMO) with process development, clinical and commercial bulk drug substance manufacturing, formulation development, clinical and commercial parenteral drug product manufacturing, including liquid and lyophilized vials, prefilled syringes and secondary packaging, and an array of support services all at a single facility in Bloomington, IN. Founded in 2004, Cook Pharmica is a division of Cook Medical, the world’s largest privately held medical manufacturing company.

About Cook Medical
Founded in 1963, Cook Medical pioneered many of the medical devices now commonly used to perform minimally invasive medical procedures throughout the body. Today, the company integrates medical devices, drugs and biologic grafts to enhance patient safety and improve clinical outcomes. Since its inception, Cook has operated as a family-held private corporation. For more information, visit www.cookmedical.com. Follow Cook Medical on Twitter @CookMedicalPR.